Amneal's Generic Thiothixene Receives Approval in the U.S.
Novitium Pharma LLC is pleased to announce that it has received U.S. Food and Drug Administration approval of its Abbreviated New Drug Application (“ANDA”) for Thiothixene Capsules USP, and has immediately initiated limited distribution activities. Thiothixene Capsules USP 1mg, 2mg, 5mg, and 10mg are all listed on the FDA’s drug shortages list. Thiothixene Capsules USP is a therapeutic equivalent to the reference listed drug Navane® Capsules of Pfizer Inc
Novitium Pharma`s Generic Thiothixene Receives Approval in US